首页> 外国专利> METHODS AND COMPOSITIONS TO ALTER TISSUE SUSCEPTIBILITY TO IMMUNE INJURY, TO PROGRAMMED CELL DEATH, AND TO CLEARANCE BY THE RETICULOENDOTHELIAL SYSTEM

METHODS AND COMPOSITIONS TO ALTER TISSUE SUSCEPTIBILITY TO IMMUNE INJURY, TO PROGRAMMED CELL DEATH, AND TO CLEARANCE BY THE RETICULOENDOTHELIAL SYSTEM

机译:通过网状内皮系统改变组织对免疫损伤,编程性细胞死亡和清除的敏感性的方法和组合物

摘要

A method for extending the viability of mammalian cells or tissues comprising the step of inhibiting the expression of native PL scramblase within the cell or tissue is disclosed. In another embodiment of the invention, a method of decreasing the viability, metastatic or invasive potential of cancer cells, cancerous tissue, or viral-infected cell by causing increased expression or activity of PL scramblase protein within the cell or tissue is disclosed.
机译:公开了一种用于延长哺乳动物细胞或组织的生存力的方法,该方法包括抑制细胞或组织内天然PL scramblase表达的步骤。在本发明的另一个实施方案中,公开了一种通过引起细胞内或细胞内PL scramblase蛋白的表达或活性增加而降低癌细胞,癌组织或病毒感染细胞的活力,转移或侵袭潜能的方法。

著录项

  • 公开/公告号EP1047779A2

    专利类型

  • 公开/公告日2000-11-02

    原文格式PDF

  • 申请/专利权人 BLOOD CENTER RESEARCH FOUNDATION;

    申请/专利号EP19990903179

  • 发明设计人 SIMS PETER J.;WIEDMER THERESE;ZHAO JI;

    申请日1999-01-19

  • 分类号C12N15/12;C07K14/47;C12N15/11;A61K38/17;A61K31/70;C12Q1/68;G01N33/68;A61K48/00;

  • 国家 EP

  • 入库时间 2022-08-22 01:46:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号